APOA1 and cardiovascular disorder: Autoantibodies against the main protein component of high-density lipoprotein (HDL) and apolipoprotein A-1 (anti-ApoA-1 IgG) have become recognized as an independent biomarker for cardiovascular disease and death throughout the last 10 years [5, 6].